Delivery Order SPE2DB22D1002-SPE2DB25FLFC0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,147.00 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (50-count unit dose) on April 24, 2025, with a completion date of April 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.54 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Refresh Plus 0.5% eye drops (30-count units) with a contract value of $1,476.04. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order valued at $1,243.20 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on July 24, 2025, with completion targeted for July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Refresh Plus 0.5% Eye Drops (50-unit packages) under a firm fixed-price contract valued at $7,137.89. This is a non-set-aside competitive award with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This award represents a...
- The Defense Logistics Agency awarded a $2,845.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) with a completion date of September 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.39 to AmerisourceBergen Drug Corp on July 30, 2025, for Refresh Plus 0.5% eye drops (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, supporting federal medical procurement requirements for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,889.08 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,905.90 contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S" pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Refresh Plus 0.5% eye drops (30 units). This firm fixed price, non-set-aside contract is scheduled for completion by August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical Supply Chain operations. This...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFC0Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,719.02 delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (70 unit dose vials) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/21/25 |